Results 161 to 170 of about 3,268,362 (310)
The Irish Human Rights Commission (IHRC) is Ireland’s National Human Rights Institution (NHRI), set up by the Irish Government under the Human Rights Commission Acts 2000 and 2001.1 The IHRC has a statutory remit under the Human Rights Commission Act ...
Irish Human Rights Commission (IHRC)
core
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu +3 more
wiley +1 more source
Public Health Policy Responses to Population Aging in Mexico: A Rights-Based and Socio-Legal Approach. [PDF]
Rojas P +5 more
europepmc +1 more source
Sexual Harassment is Discrimination
Sexual Harassment is Sex Discrimination -- Recognizing Sexual Harassment -- Categories of Sexual Harassment -- The Six Components of Sexual Harassment -- Types of Behaviors Which May be Labeled as Sexual Harassment -- First Type of Sexual Harassment ...
Kansas Human Rights Commission.
core
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Human Rights, Group Rights, and Peoples' Rights
openaire +2 more sources
Ohio Legal Rights Service quarterly
Began with Issue 1, v. 1 (Summer 2002); - Vol. 5, issue 5 (Nov. 2007); Winter 2008-; "The News from Ohio Legal Rights Service, Ohio's Protection & Advocacy System for People with Disabilities."; Description based on: Vol. 5, issue 5 (Nov.
Ohio Legal Rights Service.
core
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
A Health Rights Impact Assessment Guide for Artificial Intelligence Projects [PDF]
Carmel Williams
doaj
Inclusive Education without Paradigm Change: Explaining Thailand's Misalignment with the Salamanca Vision. [PDF]
Deeod P.
europepmc +1 more source

